Literature DB >> 27617520

Plasmablastic lymphoma: an atypical cutaneous presentation of a rare entity.

Fernando Mota1, Bruno Mesquita, S Carvalho, André Coelho, Glória Velho, Margarida Lima, Manuela Selores.   

Abstract

Plasmablastic lymphoma is a very rare B-cell lymphoma typically associated with immunosuppression: It occurs primarily in the oral cavity, although some cases were reported in other organs and tissues.To date, only 10 cases of primary cutaneous plasmablastic lymphoma have been described. Clinically, primary cutaneous plasmablastic lymphoma presents as non-specific cutaneous lesions (purple nodules, erythematous infiltrated plaques). In previously described cases, as in this case, histology and immunohistochemistry are required to make the diagnosis. Owing to the rarity of this entity, there is no established therapy, which makes its management an individualized, patient-based decision.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27617520

Source DB:  PubMed          Journal:  Dermatol Online J        ISSN: 1087-2108


  1 in total

1.  Immunosuppression-associated primary cutaneous plasmablastic lymphoma secondary to romidepsin.

Authors:  Collin M Costello; Connor J Maly; Sam Snider; Kevin J Severson; David J DiCaudo; Allison C Rosenthal; Donald W Northfelt; William Rule; Fiona E Craig; Mark R Pittelkow; Aaron R Mangold
Journal:  JAAD Case Rep       Date:  2019-12-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.